Tom Iarocci, MD

TI2.jpg

Highlights

  • Doctor with clinical and research experience in hematology and oncology
  • Advocate for those dealing with blood cancer
  • Studied national trends in cancer treatment at the American College of Radiology, with his contributions to the Digital Mammographic Imaging Screening Trial acknowledged by the New England Journal of Medicine

Experience

Dr. Iarocci's professional career began at the American College of Radiology in Philadelphia. As a research associate, he studied patterns and trends in cancer treatment across the nation, meeting Radiation Oncologists from nearly all 50 states.

Clinical trials and surveys he worked on focused on blood cancers but also treatment planning and radiation therapy for malignancies of the breast, lung, cervix, and esophagus.

An independent writing professional since 2007, Dr. Iarocci has authored and edited many health articles for websites including WebMD, Medscape, MedPage Today, and MDLinx.

By engaging clients in the pharmaceutical industry, he gained an understanding of the drug development pathway, an appreciation for brand management and online marketing, and in so doing, he developed a built-in way to keep current with the rapid changes in medicine and in hematology-oncology. In one of these collaborations, he spent two years covering leukemia, lymphomas and other blood cancers, with a special emphasis on bulky malignancies and the risk of tumor lysis syndrome.

During his time as Chief Medical Adviser at SymptomFind, Dr. Iarocci enjoyed reaching a non-medical patient audience, taking technical, clinical topics and distilling them down into plain English. He also enjoys using social media to make connections with people from all different walks of life.

Education

Dr. Iarocci received his MD from the University of Maryland School of Medicine in Baltimore. His master’s thesis was on antibiotic-resistant bacteria—specifically the kind that tend to cause bloodstream infections in bone marrow transplant patients and in people with decreased white blood cells due to chemotherapy.

During his clinical rotations and afterward, he became familiar with patient care in hematology and oncology, and recalls time spent in the bone marrow transplant unit. In addition to keeping up to date through project-based work for clients, he recently studied bioinformatics at Oregon Health and Science University.

A Word From Tom Iarocci, MD

There is still the opportunity for healing, even when a cure seems out-of-reach.

Disclaimer: I do not control what appears in the "wrapper" around my articles.

About Verywell and Dotdash

Verywell, a Dotdash property, is a friendly resource where you can explore a full spectrum of health and wellness topics, from comprehensive info on medical conditions to useful advice on fitness, nutrition, mental well-being, pregnancy, and more. We take a human approach to health and wellness, delivering accessible solutions and offering a welcome alternative to clinical sites.

Our writers not only have a deep proficiency in the topics they cover, but an undeniable passion to help others live and feel their best. Our articles are written by experienced healthcare professionals and industry experts and are vetted by board-certified physicians. We work hard to make sure that everything you read is not only accurate and comprehensive, but also trustworthy and actionable. And our content is regularly updated to ensure that we only deliver top quality information to you. We cut through all the clutter so you and your loved ones can start living Verywell.

Read more from Tom Iarocci, MD